Oncolytics Biotech (ONCY) Tops Q1 EPS by 2c

Oncolytics Biotech (NASDAQ: ONCY) reported Q1 EPS of ($0.09), $0.02 better than the analyst estimate of ($0.11).

For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.

You May Also Be Interested In

• Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
• Artiva Biotherapeutics, Inc. (ARTV) Misses Q2 EPS by 63c
• Douglas Elliman (DOUG) Reports Q2 Loss of $0.05